Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Director · Chief Executive Officer | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 590,766 |
Reported balance
After 2026-09-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 27,400 · Balance 590,766 F1: Date of Rule 10b5-1 plan adoption: 05/27/2026 F2: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. |
| Common StockSEC Table I · non-derivative | Direct | 1,223,473 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,223,473 |
Filing footnotes · ownership attribution and instrument terms
F1: Date of Rule 10b5-1 plan adoption: 05/27/2026
F2: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 21:57 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 27,400 | $13.00 | $356,200.00 |
DisclosureSEC source: 0001628280-26-062329 · wk-form4_1789595865.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 590,766 F1 · kind: Date of Rule 10b5-1 plan adoption: 05/27/2026 F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 11, 2026 Filed Sep 12, 2026 00:38 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 385,270 | $12.68 | $4,885,223.60 |
DisclosureSEC source: 0001628280-26-061620 · wk-form4_1789173489.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,223,473 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.394 to $13.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 10, 2026 Filed Sep 12, 2026 00:38 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 172,600 | $12.96 | $2,236,447.24 |
DisclosureSEC source: 0001628280-26-061620 · wk-form4_1789173489.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 618,166 F1 · kind: Date of Rule 10b5-1 plan adoption: 05/27/2026 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.71 to $13.21. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 22:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 298,000 | $13.88 | $4,136,776.40 |
DisclosureSEC source: 0001628280-26-055418 · wk-form4_1786400056.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 790,766 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.62 to $14.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 20:47 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 18,356 | $20.65 | $378,998.17 |
DisclosureSEC source: 0001628280-26-048170 · wk-form4_1784062026.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,088,766 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.55 to $20.84. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 10, 2026 Filed Jul 14, 2026 20:47 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 279,644 | $19.81 | $5,540,362.86 |
DisclosureSEC source: 0001628280-26-048170 · wk-form4_1784062026.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,107,122 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.55 to $20.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:03 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 223,064 | $20.60 | $4,594,270.76 |
DisclosureSEC source: 0001628280-26-042824 · wk-form4_1781294599.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,386,766 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.12 to $20.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · balance_after: Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:03 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 74,936 | $19.65 | $1,472,350.02 |
DisclosureSEC source: 0001628280-26-042824 · wk-form4_1781294599.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,609,830 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.12 to $20.11. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · balance_after: Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:19 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 17,107 | $17.54 | $299,971.25 |
DisclosureSEC source: 0001628280-26-034621 · wk-form4_1778703563.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,508,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.22 to $17.70. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| May 11, 2026 Filed May 13, 2026 20:19 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 280,893 | $16.85 | $4,732,878.51 |
DisclosureSEC source: 0001628280-26-034621 · wk-form4_1778703563.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,525,748 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.22 to $17.16. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 13, 2026 Filed Apr 13, 2026 22:37 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 82,299 | $20.80 | $1,711,654.60 |
DisclosureSEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,806,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.26 to $21.00. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 22:37 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 13,801 | $21.38 | $295,044.68 |
DisclosureSEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,888,940 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.31 to $21.49. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 22:37 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 201,900 | $20.58 | $4,155,243.33 |
DisclosureSEC source: 0001628280-26-024978 · wk-form4_1776119869.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,902,741 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.31 to $21.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 21:48 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 117,759 | $21.40 | $2,519,489.13 |
DisclosureSEC source: 0001628280-26-024289 · wk-form4_1775684887.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,104,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.18 to $21.56. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 07, 2026 Filed Apr 8, 2026 21:48 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 132,241 | $20.67 | $2,733,421.47 |
DisclosureSEC source: 0001628280-26-024289 · wk-form4_1775684887.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,222,400 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.18 to $21.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 23, 2026 Filed Mar 23, 2026 21:36 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 118,000 | $17.48 | $2,062,439.40 |
DisclosureSEC source: 0001628280-26-020614 · wk-form4_1774301808.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,354,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/25 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.07 to $17.81. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 22:37 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 73,046 | $17.84 | $1,303,140.64 |
DisclosureSEC source: 0001628280-26-019910 · wk-form4_1773959860.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,784,868 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 21:13 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 338,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-018878 · wk-form4_1773782010.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,857,914 F1 · shares: Represents 338,434 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 22:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 2,961 | $16.99 | $50,313.02 |
DisclosureSEC source: 0001628280-26-017810 · wk-form4_1773441115.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,519,480 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.92 to $17.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 22:31 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 45,938 | $17.48 | $802,812.49 |
DisclosureSEC source: 0001628280-26-017810 · wk-form4_1773441115.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,522,441 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.035 to $18.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 10, 2026 Filed Mar 10, 2026 23:09 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $18.19 | $3,273,552.00 |
DisclosureSEC source: 0001628280-26-016617 · wk-form4_1773184167.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,472,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.86 to $18.57. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 02:50 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $20.49 | $3,687,354.00 |
DisclosureSEC source: 0001628280-26-007091 · wk-form4_1770778227.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,652,641 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.23 to $20.66. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 2,727 | $21.57 | $58,811.85 |
DisclosureSEC source: 0001628280-26-002077 · wk-form4_1768426075.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,832,641 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $21.48 to $21.67. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · balance_after: Balances in column 5 reflect the transfer on 01/08/2026 of 665,915 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 177,273 | $21.10 | $3,740,407.12 |
DisclosureSEC source: 0001628280-26-002077 · wk-form4_1768426075.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,835,368 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.48 to $21.47. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · balance_after: Balances in column 5 reflect the transfer on 01/08/2026 of 665,915 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:53 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 33,211 | $19.38 | $643,688.96 |
DisclosureSEC source: 0001628280-25-059121 · wk-form4_1767131604.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,234,294 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.23 to $19.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:53 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 572,437 | $18.71 | $10,707,777.55 |
DisclosureSEC source: 0001628280-25-059121 · wk-form4_1767131604.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,267,505 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of performance share units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.23 to $19.225. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 21:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $19.02 | $3,423,222.00 |
DisclosureSEC source: 0001628280-25-056788 · wk-form4_1765575146.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,346,726 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.84 to $19.46. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 23:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $16.32 | $2,936,772.00 |
DisclosureSEC source: 0001628280-25-051753 · wk-form4_1762990083.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,526,726 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.01 to $16.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| October 10, 2025 Filed Oct 14, 2025 20:39 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $17.29 | $3,111,480.00 |
DisclosureSEC source: 0001222028-25-000008 · wk-form4_1760474379.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,706,726 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.97 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · balance_after: Balances in column 5 reflect the transfer on 09/25/2025 of 1,693,626 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 00:04 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $16.42 | $2,954,952.00 |
DisclosureSEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,193,100 F4 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.03 to $16.73. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F6 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 00:04 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 101,110 | $16.86 | $1,704,259.61 |
DisclosureSEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,533,568 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 00:04 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 253,908 | $16.23 | $4,120,749.10 |
DisclosureSEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,634,678 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:22 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $14.60 | $2,627,838.00 |
DisclosureSEC source: 0001222028-25-000003 · wk-form4_1755116531.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,373,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 21:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 180,000 | $13.41 | $2,413,800.00 |
DisclosureSEC source: 0001628280-25-034810 · wk-form4_1752268473.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,553,100 F3 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.28 to $13.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F5 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 23:42 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $14.48 | $1,302,849.00 |
DisclosureSEC source: 0001628280-25-031961 · wk-form4_1750203769.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,733,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.23 to $14.92. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 21:45 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $15.27 | $1,374,201.00 |
DisclosureSEC source: 0001628280-25-031106 · wk-form4_1749764703.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,823,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.61 to $15.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:01 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $14.84 | $1,335,429.00 |
DisclosureSEC source: 0001628280-25-025552 · wk-form4_1747256478.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 1,913,100 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.70 to $15.15. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| April 14, 2025 Filed Apr 16, 2025 21:02 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $19.10 | $1,718,721.00 |
DisclosureSEC source: 0001628280-25-018046 · wk-form4_1744837349.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,003,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 27, 2025 Filed Mar 29, 2025 00:27 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 34,430 | $17.89 | $615,952.70 |
DisclosureSEC source: 0001628280-25-015514 · wk-form4_1743208019.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,923,186 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 01:48 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,255 | $16.96 | $207,830.09 |
DisclosureSEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,957,616 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 01:48 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 21,846 | $16.09 | $351,458.45 |
DisclosureSEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,969,871 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 01:48 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 27,535 | $16.89 | $465,082.67 |
DisclosureSEC source: 0001628280-25-013952 · wk-form4_1742435319.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,991,717 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 21:59 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 338,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013238 · wk-form4_1742248758.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,019,252 F1 · shares: Represents (i) 274,194 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 64,516 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 750 | $15.74 | $11,803.43 |
DisclosureSEC source: 0001628280-25-012654 · wk-form4_1741899605.xml · nonDerivative · entry 4 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,680,542 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F6 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.72 to $15.76. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 52,372 | $15.42 | $807,738.59 |
DisclosureSEC source: 0001628280-25-012654 · wk-form4_1741899605.xml · nonDerivative · entry 3 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,681,292 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.715. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 100 | $15.72 | $1,572.00 |
DisclosureSEC source: 0001628280-25-012654 · wk-form4_1741899605.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,093,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 21:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 89,900 | $15.36 | $1,380,657.23 |
DisclosureSEC source: 0001628280-25-012654 · wk-form4_1741899605.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,093,200 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.69. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 00:27 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 554,713 | $15.53 | $8,614,692.89 |
DisclosureSEC source: 0001628280-25-011110 · wk-form4_1741307256.xml · nonDerivative · entry 2 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,733,664 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 7, 2025 00:27 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 2,543,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-011110 · wk-form4_1741307256.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,288,377 F1 · shares: Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date. Read SEC document |
| February 11, 2025 Filed Feb 12, 2025 23:58 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 90,000 | $14.23 | $1,280,304.00 |
DisclosureSEC source: 0001628280-25-005235 · wk-form4_1739404703.xml · nonDerivative · entry 1 KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 2,183,100 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.06 to $14.375. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.